Flamingo Therapeutics

Flamingo Therapeutics works on therapeutic approaches to cancer, a field where novel mechanisms of action and targeted delivery continue to produce clinically meaningful advances. The company is part of the PMV investment portfolio, which has been actively building the Flemish biotech ecosystem alongside other holdings such as Augustine Therapeutics.